1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 9,040 | 9,300 | 10.09. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:02 | enVVeno Medical Corporation: enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand | 169 | ACCESS Newswire | Access the video webcast here IRVINE, CA / ACCESS Newswire / September 11, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today announced that its pre-recorded... ► Artikel lesen | |
| ENVVENO MEDICAL Aktie jetzt für 0€ handeln | |||||
| 27.08. | enVVeno Medical Corporation: enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference | 358 | ACCESS Newswire | Video Webcast Now Available Here IRVINE, CA / ACCESS Newswire / August 27, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company") today announced that Robert Berman, Chief... ► Artikel lesen | |
| 04.08. | enVVeno Medical Corporation: Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments | 413 | ACCESS Newswire | Published economic health study shows both short- and long-term cost-effectiveness of replacement venous value therapy versus standard-of-care treatments for deep venous CVI, generating compelling evidence... ► Artikel lesen | |
| 31.07. | enVVeno Medical wins FDA IDE for non-surgical transcatheter replacement venous valve | 1 | MassDevice | ||
| 31.07. | enVVeno Medical erhält FDA-Zulassung für zulassungsrelevante Studie | 2 | Investing.com Deutsch | ||
| 31.07. | enVVeno Medical GAAP EPS of -$5.37 misses by $2.10 | 2 | Seeking Alpha | ||
| 31.07. | enVVeno Medical Corporation: enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve | 465 | ACCESS Newswire | Company Enters the Second Half of 2026 With Tailwinds From an FDA IDE Approval, With the TAVVE Pivotal Study Expected to Begin Enrolling Patients During the Second Half of This Year and Cash Runway... ► Artikel lesen | |
| 30.07. | enVVeno Medical Corp - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 15.07. | enVVeno Medical Corporation: enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment | 430 | ACCESS Newswire | CEO Explains How Broad Patent Protection, Combined with First-Ever FDA IDE Approval, Positions enVVe to Own a Multi-Billion-Dollar Venous Disease MarketWatch the "What This Means" video here IRVINE... ► Artikel lesen | |
| 14.07. | enVVeno Medical Corp - 8-K, Current Report | - | SEC Filings | ||
| 07.07. | enVVeno Medical receives U.S. patent for venous valve system | 2 | Investing.com | ||
| 07.07. | enVVeno Medical Corporation: enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial | 766 | ACCESS Newswire | New Patent Broadly Protects Core Technology Behind Potential First Non-Surgical Replacement Venous Valve Builds on First-Ever FDA IDE Approval for Pivotal Study of enVVe System Targeting Multi-Billion-Dollar... ► Artikel lesen | |
| 22.06. | enVVeno Medical Corporation: enVVeno Medical to Present in the Webull Corporate Connect Webinar Series | 330 | ACCESS Newswire | - Live webcast on Wednesday, June 24th at 2:00 PM ET- Access the event here IRVINE, CA / ACCESS Newswire / June 22, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"),a company... ► Artikel lesen | |
| 02.06. | enVVeno Medical Corporation: enVVeno Medical to Participate in the Virtual Investor Closing Bell Series | 283 | ACCESS Newswire | Live video webcast with Robert Berman, Chief Executive Officer of enVVeno Medical, on Tuesday, June 9that 4:00 PM ETRegister here IRVINE, CA / ACCESS Newswire / June 2, 2026 / enVVeno Medical Corporation... ► Artikel lesen | |
| 12.05. | enVVeno Medical Corporation: enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment | 491 | ACCESS Newswire | First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-surgical Replacement Venous ValveIDE approval positions enVVeno to advance what could become the first effective treatment option for the... ► Artikel lesen | |
| 07.05. | enVVeno Medical GAAP EPS of -$5.89 | 3 | Seeking Alpha | ||
| 07.05. | enVVeno Medical Corporation: enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System | 735 | ACCESS Newswire | Company ended the first quarter with approximately $25 million in cash and investmentsCapital on hand should fund operations through multiple key milestones into Q3 2027Company recently received FDA... ► Artikel lesen | |
| 06.05. | enVVeno Medical Corp - 10-Q, Quarterly Report | - | SEC Filings | ||
| 29.04. | enVVeno receives FDA approval for venous valve pivotal trial | 2 | Investing.com | ||
| 29.04. | enVVeno Medical Corporation: enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve | 967 | ACCESS Newswire | First-in-Class enVVe system to be evaluated in TAVVE U.S. Pivotal TrialClinical site activation and patient enrollment expected to commence later this yearLarge unmet clinical need for approximately... ► Artikel lesen |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 38,980 | +1,27 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,690 | +0,70 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Buy" belassen. Die Innovationsdynamik bleibe hoch, schrieb Julien... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 30,920 | -0,39 % | EQS-DD: Carl Zeiss Meditec AG: Justus Felix Wehmer, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
04.09.2026 / 17:25... ► Artikel lesen | |
| ECKERT & ZIEGLER | 12,370 | +0,65 % | ALARMSTUFE ROT bei Eckert&Ziegler: 3,18% Kurseinbruch erschüttert den Markt! | ||
| INTUITIVE SURGICAL | 314,05 | +1,13 % | Intuitive Surgical: Ausblick steht - doch ein Risiko wächst | ||
| MEDTRONIC | 80,00 | +1,37 % | Jim Cramer Calls Medtronic (MDT) a "Quandary" as Growth Surges and Diabetes Exit Nears | ||
| GERRESHEIMER | 28,500 | -1,66 % | EQS-DD: Gerresheimer AG: Active Ownership Opportunities SCS, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
07.09.2026 / 15:24... ► Artikel lesen | |
| THERMO FISHER | 525,80 | +1,19 % | Wachstumsausblick überzeugt: UBS stuft Thermo Fisher Scientific auf "Kaufen" hoch | ||
| TELADOC HEALTH | 5,244 | +0,04 % | Here's Why Teladoc's Integrated Care Business Deserves More Attention | ||
| STRATEC | 24,800 | +1,64 % | Stratec-Aktie: Beginnt jetzt die Kurserholung? | Die Stratec-Aktie befindet sich seit dem Hoch während der Corona-Pandemie bei rund 140 € in einem langfristigen Abwärtstrend. Seit Jahresbeginn hat sich der Abwärtstrend jedoch deutlich abgeschwächt... ► Artikel lesen | |
| RHOEN-KLINIKUM | 14,400 | 0,00 % | 124 Nachwuchskräfte starten am RHÖN-KLINIKUM Campus Bad Neustadt in ihre berufliche Zukunft | Bad Neustadt a. d. Saale (ots) - Für 124 Nachwuchskräfte beginnt am RHÖN-KLINIKUM Campus Bad Neustadt ein neuer beruflicher Lebensabschnitt. In neun Gesundheits- und Verwaltungsberufen starten sie ihre... ► Artikel lesen | |
| M1 AESTHETICS | 13,000 | 0,00 % | Dividendenbekanntmachungen (08.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,4135 NZD 0,2059 EUR AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,35 EUR BANK OF CHONGQING CO LTD CNE100001QN2 0... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 71,40 | +1,16 % | Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 August 2026 | Eurofins Scientific SE (Paris:ERF):
ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,88 | 0,00 % | BrightSpring auf Wells Fargo Konferenz: Wachstum beschleunigt sich auf breiter Front | ||
| TENON MEDICAL | 5,340 | +0,75 % | Morning Market Movers: Tenon Medical, Shoe Station, Cooper Companies, Culp, Inc. See Big Swings | TOKYO (dpa-AFX) - At 8:20 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
ENVVENO MEDICAL CORPORATION gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 9,170 Euro und damit -100,00 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENVVENO MEDICAL CORPORATION finden Sie auf Wallstreet Online.